Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNexus Gene Lab (BGLC) Asset Utilization Ratio (2019 - 2025)

Historic Asset Utilization Ratio for BioNexus Gene Lab (BGLC) over the last 7 years, with Q3 2025 value amounting to 1.11.

  • BioNexus Gene Lab's Asset Utilization Ratio rose 3275.79% to 1.11 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.11, marking a year-over-year increase of 3275.79%. This contributed to the annual value of 0.87 for FY2024, which is 1021.33% down from last year.
  • According to the latest figures from Q3 2025, BioNexus Gene Lab's Asset Utilization Ratio is 1.11, which was up 3275.79% from 1.01 recorded in Q2 2025.
  • BioNexus Gene Lab's Asset Utilization Ratio's 5-year high stood at 1.48 during Q3 2021, with a 5-year trough of 0.82 in Q2 2024.
  • Over the past 5 years, BioNexus Gene Lab's median Asset Utilization Ratio value was 1.18 (recorded in 2021), while the average stood at 1.15.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first crashed by 7899.44% in 2021, then soared by 3275.79% in 2025.
  • Quarter analysis of 5 years shows BioNexus Gene Lab's Asset Utilization Ratio stood at 1.38 in 2021, then dropped by 4.36% to 1.32 in 2022, then crashed by 35.33% to 0.85 in 2023, then grew by 3.86% to 0.89 in 2024, then increased by 25.14% to 1.11 in 2025.
  • Its last three reported values are 1.11 in Q3 2025, 1.01 for Q2 2025, and 0.93 during Q1 2025.